InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company for the treatment of cancer and autoimmune diseases, announced today that its next generation TRK ...

Researchers in Spain have developed a new therapy protocol that could revolutionize the treatment of pancreatic cancer. Notoriously aggressive and difficult to treat, pancreatic cancer is rarely ...

It has traits that could easily be mistaken for cancerous tissue. But a new type of tumor with squishy insides cocooned in a hard, bone crust is actually benign. Now, detailed guidelines will help ...

Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable to perform their roles properly due to suppression by the tumor. A KAIST ...

While human and mice tumors share many of the same molecular markers, including many shared genes, there are differences, including our natural immune responses and our immune systems in general.

The terms tumor and cancer can refer to different types of lumps and bumps. But the terms are often confused and misused—by the general public and even health professionals. For instance, doctors can ...

A new study delving into the genetic drivers of a rare and aggressive childhood cancer called Malignant Peripheral Nerve Sheath Tumor (MPNST) has revealed metabolic frailties in the cancer cells that ...

ABSTRACT: The objective of the current study was to determine the expression profiles of the Breast Cancer genes 1 and 2, two tumor suppressing genes, in patients with breast cancer in the Gbêkê ...

Infantile fibrosarcoma (IFS) represents the most common non-rhabdomyosarcoma soft tissue tumor, with 80% of diagnoses under the first year of life. In contrast with adult fibrosarcoma, IFS has lower ...